Keep calm and keep investing.
News & Analysis: Johnson & Johnson
Its dividend already pays more than what you'd get from the average stock on the S&P 500.
They're masters of pricing, not to mention their supply chains.
Here's why you haven't missed the boat on this blue chip.
Hint: It wasn't the company's COVID-19 vaccine.
These two blue-chip pharmaceuticals pay great dividends.
These proven stocks look primed to grow your money manifold in the coming years.
If you only have time for one reason, read No. 5 first.
Investors have been embracing momentum for a while. Is that trend about to reverse?
From dividends to growth to overall stability, these stocks will give your portfolio a great mix.